CoChat

Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart

Open access
Anderson, Ethan J, Katunga, Lalage A, Willis, Monte S · 2012 · Clinical and Experimental Pharmacology and Physiology
Cited by 147

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Summary: 1. The heart is a highly oxidative organ in which cardiomyocyte turnover is virtually absent, making it particularly vulnerable to accumulation of lipid peroxidation products (LPP) formed as a result of oxidative damage. 2. Reactive oxygen and nitrogen species are the most common electrophiles formed during lipid peroxidation and lead to the formation of both stable and unstable LPP. Of the LPP formed, highly reactive aldehydes are a well‐recognized causative factor in ageing and age‐associated diseases, including cardiovascular disease and diabetes. 3. Recent studies have identified that the mitochondria are both a primary source and target of LPP, with specific emphasis on aldehydes in cardiomyocytes and how these affect the electron transport system and Ca 2+balance. 4. Numerous studies have found that there are functional consequences in the heart following exposure to specific aldehydes (acrolein,trans‐2‐hexanal, 4‐hydroxynonenal and acetaldehyde). Because these LPP are known to form in heart failure, cardiac ischaemia–reperfusion injury and diabetes, they may have an underappreciated role in the pathophysiology of these disease processes. 5. Lipid peroxidation products are involved in the transcriptional regulation of endogenous anti‐oxidant systems. Recent evidence demonstrates that transient increases in LPP may be beneficial in cardioprotection by contributing to mitohormesis (i.e. induction of anti‐oxidant systems) in cardiomyocytes. Thus, exploitation of the cardioprotective actions of the LPP may represent a novel therapeutic strategy for future treatment of heart disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.2011.05641.x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 147

Metadata

Authors
Anderson, E. J., Katunga, L. A., & Willis, M. S.
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
2012-01-30
Volume
39
Issue
2
Pages
179-193
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W2138632104
Cited by
147
References
19
FWCI
5.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. https://app.cochat.ai/papers/10.1111/j.1440-1681.2011.05641.x
The paper
Anderson, E. J., Katunga, L. A., & Willis, M. S. (2012). Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.2011.05641.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.